(Q33498453)

27 July 2017

1 reference

title

Animal models for antiphospholipid syndrome in pregnancy. (English)

1 reference

antiphospholipid syndrome

27 July 2017

main subject

1 reference

3

Shoenfeld Y

1 reference

27 July 2017

2

Blank M

1 reference

27 July 2017

Ziporen L

1

1 reference

27 July 2017

publication date

1 February 1997

1 reference

Rheumatic Diseases Clinics of North America

27 July 2017

published in

1 reference

27 July 2017

volume

23

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

99-117

1 reference

Early onset of autoimmunity in MRL/++ mice following immunization with beta 2 glycoprotein I.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Antiphospholipid syndrome and the idiotypic network

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Induction of tolerance by monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Suppression of experimental systemic lupus erythematosus (SLE) with specific anti-idiotypic antibody-saporin conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Induction of Tolerance to Experimental Anti‐Phospholipid Syndrome (APS) by Syngeneic Bone Marrow Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Obstetric complications associated with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Model for the neuromuscular complications of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

The possible role of prolactin in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Treatment of habitual abortions associated with autoimmune abnormalities. A report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Pathogenic natural anti-cardiolipin antibodies: the experience from monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Manipulating the Immune System with Immune Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Low-dose aspirin in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Autoantibodies and pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Fetal loss treatment in patients with antiphospholipid antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Antiphospholipid antibodies in an in vivo thrombosis model in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human beta 2 glycoprotein 1 or anticardiolipin antibodies alone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Rabbits produce SLE-like anti-RNA polymerase I and anti-DNA autoantibodies in responses to immunization with either human or murine SLE anti-DNA antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Idiotypic induction of autoimmunity: a new aspect of the idiotypic network.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Effect of long-acting thromboxane receptor antagonist (BMS 180,291) on experimental antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Antiplatelet activity of the long-acting thromboxane receptor antagonist BMS 180,291 in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Induction of high levels of anticardiolipin antibodies in mice by immunization with beta 2-glycoprotein I does not cause fetal death

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Suppression of experimental antiphospholipid syndrome and systemic lupus erythematosus in mice by anti-CD4 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Antiphospholipid antibodies and recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

Self-nonself discrimination by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

The cytokine basis for cross-talk between the maternal immune and reproductive systems

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970317-3

7 January 2021

10.1016/S0889-857X(05)70317-3

Identifiers

DOI

1 reference

27 July 2017

1 reference